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Abstract
A 65-year-old woman presented with abdominal pain, weight loss, fatigue, and microcytic anemia.
Esophagogastroduodenoscopy, until the second part of duodenum, was normal. Ultrasound and
computed tomography demonstrated a solid mass in the distal duodenum. A repeat endoscopy
confirmed an ulcerative, intraluminar mass in the third and fourth part of the duodenum. Segmental
resection of the third and fourth portion of the duodenum was performed. Histology revealed an
adenocarcinoma. On the 4th postoperative day, the patient developed severe acute pancreatitis
leading to multiple organ failure and died on the 30th postoperative day.
Introduction
Although the small intestine constitutes over 75% of the
length and 90% of the mucosal surface of the gastrointes-
tinal tract, small intestine cancer is rare and accounts for
only 1% of gastrointestinal malignancies [1,2]. Adenocar-
cinoma together with carcinoid tumours are the most
common histological types of primary malignant
tumours of the small bowel but other, including lym-
phoma and leiomyosarcoma, may less frequently be
encountered [1,2]. Adenocarcinomas are predominantly
located in the duodenum [1,2].
Duodenal adenocarcinomas represent approximately
0.3% of all malignant gastrointestinal tumours and the
vast majority of them is found in the second portion of the
duodenum [1,2]. Adenocarcinomas of the third and/or
fourth portion of the duodenum, however, are very rare
[1,2]. A case of adenocarcinoma of the third and fourth
part of the duodenum is presented along with a literature
review.
Case presentation
A 65-year-old Greek woman (weight: 80 kgr, height: 160
cm) with a free past and family history, presented with a
two month history of intermittent abdominal pain,
weight loss, and fatigue. The patient had two normal
labours, while she did not smoke, consume alcohol or
take any medication. Clinical examination was normal.
Blood tests, including tumour markers such as carcinoem-
bryonic antigen (CEA), a-fetoprotein (AFP), carbohydrate
antigen 19-9 (CA 19-9), and carbohydrate antigen 125
(CA 125), were within normal limits apart from micro-
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cytic anemia (hemoglobin: 8.0 gr/dl). Esophagogastrodu-
odenoscopy, until the second portion of the duodenum,
was normal. Abdominal ultrasound (US) finding of a
hypoechoic mass with irregular margins in the distal duo-
denum led to a contrast-enhanced abdominal computed
tomography (CT) scan that revealed a solid mass (6 × 5
cm) in the third and fourth part of the duodenum (Figure
1). No proximity to the stomach, pancreas, second por-
tion of the duodenum, duodenojejunal flexure, proximal
jejunum or colon was demonstrated. Portal vein, celiac
axis, superior mesenteric artery and vein, pancreatic and
bile duct were also free of tumour. No lymph node or dis-
tant metastasis was identified. Due to US and CT findings,
a second endoscopy was performed which confirmed an
ulcerative, intraluminar mass in the third and fourth part
of the duodenum. Histology demonstrated an adenocar-
cinoma.
Intraoperatively, a solid mass in the third and fourth part
of the duodenum was identified. Local resectability of the
tumour was meticulously investigated. Kocher's manoeu-
vre, mobilisation of the large intestine from the cecum to
the midpoint of the transverse colon, mobilisation of the
small bowel mesentery, division of the ligament of Treitz,
and mobilisation of the third and fourth part of the duo-
denum along with the duodenojejunal flexure and proxi-
mal jejunum was performed. The stomach, pancreas,
second portion of the duodenum, duodenojejunal flex-
ure, proximal jejunum, and colon were free of tumour.
Portal vein, celiac axis, superior mesenteric artery and
vein, pancreatic and bile duct were also free of tumour. No
lymph node or distant metastasis was identified. The neo-
plasm was, thus, considered resectable and a segmental
resection of the third and fourth portion of the duodenum
along with regional mesentery was performed. Intestinal
continuity was then restored by an end-to-end hand sewn
duodenojejunal anastomosis. Histopathologic evaluation
of the resected specimen verified a moderately differenti-
ated adenocarcinoma, measuring approximately 9 × 6 cm,
infiltrating the duodenal wall, without any lymph node
involvement (T3N0M0) (Figure 2). The specimen's mar-
gins were free of tumour.
On the 4th postoperative day, the patient developed severe
acute pancreatitis and was admitted to the Intensive Care
Unit. She developed multiple organ failure and died on
the 30th postoperative day.
Discussion
Few cases of adenocarcinoma of the third and/or fourth
portion of the duodenum have been reported [3-11].
Causative factors have not been clearly identified [5].
Abdominal contrast-enhanced CT scan revealing a mass in the third and fourth part of the duodenum Figure 1
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Patients with familial adenomatous polyposis (FAP) and
Gardner syndrome are considered to have a higher likeli-
hood of developing duodenal cancer [12,13]. Patients
who have duodenal polyps without a predisposing family
history are also at an increased risk [5].
Adenocarcinoma of the third or fourth part of the duode-
num presents a diagnostic challenge. Symptoms may be
absent until the tumour has progressed leading to a delay,
of several months, in presentation [5,7,8]. The most com-
mon presenting symptom is abdominal pain; other clini-
cal manifestations are nausea, vomiting, weight loss,
anemia, fatigue, weakness, gastrointestinal bleeding or
obstruction [4,5,7-11]. Diagnosis is also often delayed
due to the vague and non-specific symptoms and the sub-
sequent difficulties in performing the relevant investiga-
tion, while most patients undergo a number of diagnostic
tests before surgical exploration [2,5-8,11]. Moreover,
Cunningham reported that preoperative diagnosis was
obtained in 6 of 13 such tumours [8]. The majority of
these tumours have infiltrated through the duodenal wall
at presentation with many being irresectable due to local
and distant invasion [1,5,7-11].
Diagnosis is usually made by upper gastrointestinal con-
trast study and endoscopy [4,5,7-11]. Their location, how-
ever, is often inaccessible to endoscopic viewing which
may result in failure to diagnose them at endoscopy
[5,8,10]. In some cases [6,8], US or CT findings have
prompted repeat endoscopy with advancement deeper
than usual, into the third and fourth duodenal portion,
leading to diagnosis as in our patient. Patients may have
at least one negative gastrointestinal contrast study before
a positive result on a subsequent study [5]. Endoscopy
with extra-long fibre optic scopes may be of benefit.
Abdominal US is helpful for diagnosis and evaluation of
vascular involvement [6,8]. Lesions appear as irregularly
marginated hypoechoic masses but tumours smaller than
2 cm may not be detected [6]. Contrast-enhanced CT scan
is useful for diagnosis and determination of malignancy
and resectability [4,5,8,10,14]; however, tumours smaller
than 2 cm may not be seen [14]. Features indicating
malignancy are an exophytic or intramural mass, central
necrosis, and ulceration while entirely intraluminal loca-
tion indicates a benign tumour [14]. These features,
though, are sensitive but non-specific. Vascular encase-
ment, invasion of contiguous organs other than the head
of the pancreas, distant lymphadenopathy, or metastases
precludes curative resection [14]. Endoscopic US and
magnetic resonance imaging (MRI), although not fre-
quently used so far, are useful for the diagnosis, staging,
and determination of resectability of these tumours.
The treatment of choice is radical surgical resection [2,4-
11]. The correct operation (pancreaticoduodenectomy,
local excision or segmental resection) has been debated.
Worldwide there is no general attitude on optimal surgical
procedure in treatment of primary non-ampullary adeno-
carcinoma of the duodenum, especially for early stage dis-
ease. Due to its rarity, there is a lack of studies comparing
local excision, segmental resection and Whipple proce-
dure in the management of this neoplasm. Some authors
prefer local excision or segmental resection while others
duodenopancreatic resection, even in the case of early
stage duodenal cancer with aim to avoid tumour recur-
rence, considering pancreaticoduodenectomy the proce-
dure that satisfies the principles of an adequate curative
cancer operation. Heniford [7], Santoro [9], and Barnes
[10] reviewed 12, 33, and 67 patients with non-ampullary
adenocarcinoma of the duodenum, respectively; no sig-
nificant difference between pancreaticoduodenectomy,
wide local excision or segmental resection was observed
while tumour stage and resectability were the only predic-
tive factors of survival identified. Moreover, in a study of
47 patients by Tocchi [5], no statistically significant differ-
ence was found between patients who underwent duode-
nal segmentectomy and those undergoing
pancreaticoduodenectomy in terms of local recurrence,
distant metastases, disease-free survival and overall sur-
vival. However, statistically significantly higher blood
transfusion requirement, hospital stay, morbidity, and
mortality were noted in the pancreaticoduodenectomy
group. Factors influencing survival were TNM staging and,
particularly, lymph node status. The authors suggested
that duodenal segmentectomy may be preferred to pan-
creaticoduodenectomy because it is associated with low
rates of morbidity and mortality, while exerting similar
Histopathology verified infiltration of the duodenal wall by an  adenocarcinoma Figure 2
Histopathology verified infiltration of the duodenal 
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results [5]. It should be noted, though, that local recur-
rence after wide local excision of early stage disease has
been reported [3]. Regardless of the type of surgery, cura-
tive resection results in a significant survival advantage
compared to noncurative resection or nonoperative man-
agement [4,5,7-10]. In advanced disease, and particularly
in duodenal obstruction, palliative resection, gastrojeju-
nal bypass or duodenal stents may be indicated. In our
case, segmental resection was performed. Our patient died
due to severe acute pancreatitis leading to fatal systemic
inflammatory response syndrome a complication that has
also been reported by others [4].
Little is known about the use of radiotherapy and chemo-
therapy, but most physicians utilise therapeutic strategies
modeled on the management of large bowel cancer [2].
Cunningham observed no significant benefit of adjuvant
chemotherapy on survival [8]. The prognosis is generally
poor and depends on stage at presentation and surgical
resectability [2,5-10]. Prolonged survival following com-
plete resection is possible while irresectable disease has a
very poor prognosis [4,5,7-11]. Selective, individualised
use of pancreaticoduodenectomy, wide local excision or
segmental resection as surgical treatment options seems to
provide a rational approach to this rare disease.
Conclusion
Adenocarcinoma of the third and fourth part of the duo-
denum is very rare. Patients typically present with a long
history of variable, vague symptoms and, many, with
advanced disease. A higher degree of suspicion and a more
aggressive, persistent investigation should lead to earlier
treatment, higher curative resectability rate, and, there-
fore, better long-term results. The treatment of choice is
radical surgical resection. The optimal surgical procedure,
though, remains controversial. Multi-institutional pro-
spective studies comparing pancreaticoduodenectomy
with segmental resection or wide local excision as well as
trials of chemotherapy and radiation therapy are needed
to identify their impact on prognosis and suggest appro-
priate treatment recommendations.
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